These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19272188)

  • 1. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
    Chiang KC; Lai LP; Shieh RC
    J Biomed Sci; 2009 Aug; 16(1):76. PubMed ID: 19706159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
    Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R
    Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
    Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.
    Hu D; Barajas-Martinez H; Burashnikov E; Springer M; Wu Y; Varro A; Pfeiffer R; Koopmann TT; Cordeiro JM; Guerchicoff A; Pollevick GD; Antzelevitch C
    Circ Cardiovasc Genet; 2009 Jun; 2(3):270-8. PubMed ID: 20031595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
    Makita N; Mochizuki N; Tsutsui H
    Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
    Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
    Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
    Makita N; Sumitomo N; Watanabe I; Tsutsui H
    Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
    Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA
    Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brugada syndrome.
    Escárcega RO; Jiménez-Hernández M; Garcia-Carrasco M; Perez-Alva JC; Brugada J
    Acta Cardiol; 2009 Dec; 64(6):795-801. PubMed ID: 20128157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations of the Navβ1b sodium channel subunit in human ventricle; functional characterization of the H162P Brugada syndrome mutant.
    Yuan L; Koivumäki JT; Liang B; Lorentzen LG; Tang C; Andersen MN; Svendsen JH; Tfelt-Hansen J; Maleckar M; Schmitt N; Olesen MS; Jespersen T
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1204-12. PubMed ID: 24561865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
    Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M
    Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
    London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
    Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.